Seoul National University College of Engineering (SNU Engineering) announced that a joint research team led by Prof. Sunghoon ...
Around 40% of adults worldwide are affected by osteopenia: a loss of bone mineral density. This condition is extremely common ...
Normal, regulated growth of skeletal bones is a crucial part of the growth of mammals. This is a complex process involving the growth of cartilaginous cells or chondrocytes, their transformation into ...
A recent study identifies Neural EGFL-like 2 (NELL2), a secreted protein, as a key regulator of bone homeostasis, offering potential therapeutic applications for osteoporosis. NELL2 promotes ...
Drug trial shows reduced abnormal bone formation in those with fibrodysplasia ossificans progressiva
As flare-ups often precede the formation of new lesions, we are encouraged that this investigational drug may help prevent the progression of FOP. "The loss of mobility created by the abnormal bone ...
A new small molecule could treat and prevent excess bone formation. Fibrodysplasia ossificans progressiva (FOP) is an extremely rare disease estimated to affect about one in 2 million people worldwide ...
Please provide your email address to receive an email when new articles are posted on . Ceramic biomaterial remodeled into cancellous bone at 3 months postoperatively and densified at 6 months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results